FDA Extends Target Date for Eylea
>> Monday, August 29, 2011
The US Food and Drug Administration, usually referred to by the acronym FDA, has extended the target date for the drug’s approval by three months. A decision had been expected in August, but the FDA has announced that a final decision will be delayed until November 18 while the agency evaluates and categorises company responses to agency questions.
Read more...
Posts
